Smith & Nephew

Latest Headlines

Latest Headlines

Smith & Nephew hit by setback as PhIII regenerative med study flops

Last spring a prominent analyst suggested that a successful late-stage study for Smith & Nephew's spray-on cell therapy for wound healing could be a catalyst to break up the company a la Abbott and Baxter. But today, the discussion of the much buzzed-about trigger event turned bitter after the company reported that the Phase III trial flopped.

EU regulators to conduct antitrust probe of $13.4B Zimmer/Biomet deal

The European Union's antitrust unit is worried that Zimmer's $13.4 billion bid for crosstown rival Biomet will limit competition and wants to look into the deal further.

ArthroCare $750M fraud saga culminates in decades-long prison term

Cooking the books doesn't pay. That's the message the U.S. Department of Justice sent with the strict sentence it got for ArthroCare executives—albeit almost a decade after the problematic bookkeeping practices began.

Smith & Nephew touts acquisitions, offers bulk hospital buying

Smith & Nephew is targeting a serious margin ramp-up and tax rate reductions within the next few years. Maintaining its aggressive acquisition strategy is an obvious means to work toward both those goals.

Smith & Nephew partners with startup for knee surgical system

Orthopedic specialist Smith & Nephew will market Blue Belt's surgical knee system in a worldwide agreement that could help breathe fresh life into Smith & Nephew's flagging knee implant revenue growth. The partnership with Smith & Nephew is the startup's first major distribution deal.

Medtronic considers bid for Smith & Nephew amid building med dev merger mania

Already a global giant in medical devices, Medtronic is considering growing even larger with a possible bid for Smith & Nephew, which has been the subject of M&A talk for the past few weeks following reports Stryker would seek to buy the U.K. maker of hip and knee replacements.

Former ArthroCare top execs convicted of securities fraud scheme

A federal jury convicted the former CEO and CFO of medical device company ArthroCare on Monday. The pair used fancy accounting that falsely recorded tens of millions in revenue, according to the U.S. Department of Justice. 

Stryker CEO clears the air regarding Smith & Nephew deal

After rumors circulated that Stryker would lay down a bid for orthopedics rival Smith & Nephew, Stryker CEO Kevin Lobo confirmed that his company is considering a deal--even if it doesn't plan to make an offer anytime soon.

Stryker denies interest in Smith & Nephew, but leaves the door open to a deal

Stryker denied a Wednesday story in the  Financial Times  saying that it was preparing to make a bid for orthopedics rival Smith & Nephew, but cited a section of the takeover code which would allow it to make an offer within 6 months.

Smith & Nephew puts up $12M to clear the way for its $1.7B ArthroCare deal

Smith & Nephew, the U.K. orthopedic giant, has agreed to pay $12 million to settle a shareholder lawsuit blocking its $1.7 billion acquisition of ArthroCare, according to a SEC filing.